Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Lemoine

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|October 21, 2022
[New European approval: Brexucabtagene autoleucel in adult relapsed/refractory acute lymphoblastic leukemia]Jean Lemoine, Tony Marchand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Overcoming Intrinsic Resistance of Cancer Cells to CAR T-Cell KillingJean Lemoine, Marco Ruella, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|December 6, 2021
Disease-specific outcomes after chimeric antigen receptor T-cell therapyJean Lemoine, Samuel Vic, Roch Houot
Journal of Hematology & Oncology|November 23, 2021
Born to survive: how cancer cells resist CAR T cell therapyJean Lemoine, Marco Ruella, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experienceMathilde Guégan, Malvina Bichon, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2022
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant populationSamuel Vic, Jean Lemoine, Philippe Armand, et al.
British Journal of Haematology|February 27, 2024
Management of immunosuppression in post-transplant lymphoproliferative disorders treated with CAR T cellsNathacha Jimkap, Oussama El Baroudi, Jean Lemoine, et al.
Current Research in Translational Medicine|February 27, 2021
Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: A case reportJean Lemoine, Agnes Bonnin, Zora Marjanovic, et al.
Scientific Reports|July 4, 2020
Finding hotspots: development of an adaptive spatial sampling approachRicardo Andrade-Pacheco, Francois Rerolle, Jean Lemoine, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|October 21, 2022
[New European approval: Brexucabtagene autoleucel in adult relapsed/refractory acute lymphoblastic leukemia]Jean Lemoine, Tony Marchand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Overcoming Intrinsic Resistance of Cancer Cells to CAR T-Cell KillingJean Lemoine, Marco Ruella, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|December 6, 2021
Disease-specific outcomes after chimeric antigen receptor T-cell therapyJean Lemoine, Samuel Vic, Roch Houot
Journal of Hematology & Oncology|November 23, 2021
Born to survive: how cancer cells resist CAR T cell therapyJean Lemoine, Marco Ruella, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|November 30, 2024
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experienceMathilde Guégan, Malvina Bichon, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2022
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant populationSamuel Vic, Jean Lemoine, Philippe Armand, et al.
British Journal of Haematology|February 27, 2024
Management of immunosuppression in post-transplant lymphoproliferative disorders treated with CAR T cellsNathacha Jimkap, Oussama El Baroudi, Jean Lemoine, et al.
Current Research in Translational Medicine|February 27, 2021
Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: A case reportJean Lemoine, Agnes Bonnin, Zora Marjanovic, et al.
Scientific Reports|July 4, 2020
Finding hotspots: development of an adaptive spatial sampling approachRicardo Andrade-Pacheco, Francois Rerolle, Jean Lemoine, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
Pageof 2